Back

Novo Nordisk Reports Positive Mid-Stage Trial Results for Obesity Drug

The Denmark-based pharmaceutical company announced promising outcomes for its next-generation obesity treatment in a phase II clinical study.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Phase II clinical trial: A mid-stage study to assess a drug's efficacy and side effects in a larger group of participants.